IDXX innovation, commercial expansion lift recurring revenue
The company cites strong Q2 performance and raised guidance, attributing growth to innovation adoption and higher diagnostic utilization.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.